Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth.
Sighel, D., Notarangelo, M., Aibara, S., Re, A., Ricci, G., Guida, M., Soldano, A., Adami, V., Ambrosini, C., Broso, F., Rosatti, E.F., Longhi, S., Buccarelli, M., D'Alessandris, Q.G., Giannetti, S., Pacioni, S., Ricci-Vitiani, L., Rorbach, J., Pallini, R., Roulland, S., Amunts, A., Mancini, I., Modelska, A., Quattrone, A.(2021) Cell Rep 35: 109024-109024
- PubMed: 33910005 
- DOI: https://doi.org/10.1016/j.celrep.2021.109024
- Primary Citation of Related Structures:  
6I9R - PubMed Abstract: 
Glioblastoma stem cells (GSCs) resist current glioblastoma (GBM) therapies. GSCs rely highly on oxidative phosphorylation (OXPHOS), whose function requires mitochondrial translation. Here we explore the therapeutic potential of targeting mitochondrial translation and report the results of high-content screening with putative blockers of mitochondrial ribosomes ...